Assessment of biotechnology drugs: What are the issues?

1999-05-02

Health Policy , Volume 47 - Issue 3 p. 255- 274

Additional Metadata
Keywords	Biotechnology, Drug policy, Health care decision making, Technology assessment
Persistent URL	doi.org/10.1016/S0168-8510(99)00017-2, hdl.handle.net/1765/71766
Journal	Health Policy
Organisation	Department of Cardio-Thoracic Surgery
Citation APA APA Style APA-ALL Style AAA Style Cell Style Chicago Style Harvard Style IEEE Style MLA Style Nature Style Vancouver Style American-Institute-of-Physics Style Council-of-Science-Editors Style BibTex Format Endnote Format RIS Format CSL Format DOIs only Format	van Rijkom, J., Leufkens, H., Crommelin, D. J. A., Rutten, F.& Broekmans, F. (1999). Assessment of biotechnology drugs: What are the issues?. In Health Policy (Vol. 47, Number 3, pp. 255–274).https://doi.org/10.1016/S0168-8510(99)00017-2

Publication